1. HIV and the ART of Prevention

2. Estimated New HIV Infections By Transmission Category 2002 vs 2011

3. Estimated New HIV Infections By Transmission Category 2002 vs 2011 (cont)

4. SAFE A Serostatus Approach to Fighting the Epidemic

5. SAFE 5 Steps for HIV Prevention

6. HIV Continuum of Care

7. Barriers to Implementing SAFE

8. Preventing Transmission Requires A Multifaceted Strategy

9. High-impact Prevention Approach to Reducing New HIV Infections

10. HIV Prevention Begins With Knowledge of Serostatus

11. PrEP

12. iPrEx Study Oral TDF/FTC Once Daily Effective in Preventing HIV Infection (N = 2499)

13. Partners PrEP Safe and Effective for Serodiscordant Heterosexual Couples

14. Studies of PrEP Using Antiretrovirals to Prevent HIV Infection

15. PrEP Guidance

16. PrEP Guidance (cont)

17. HPTN 052 Study Early ART Reduces HIV-1 Transmission in Serodiscordant Couples From The Infected to the Uninfected Partner

18. Effective ART Reduces the HIV Transmission Risk of Condomless Sex From Efficacy to Effectiveness

19. Overcoming Barriers to Use and Effectiveness of PrEP

20. PREP US Demo Project Baseline Risk Behaviors and PrEP Acceptance

21. Dose-response Relationship Between Adherence and Efficacy of PrEP

22. Adherence to PrEP Prescription + Counseling

23. iPrEx OLE Study Perfect Adherence Not Necessary for Effective PrEP

24. CDC and USPSTF Guideline Evolution for HIV Testing in the Medical Setting

25. Identifying Patient Candidates for PrEP

26. How Many Potential PrEP Users Are There in the United States?

27. PrEP Who and Where?

28. Before PrEP: Assessing High-risk Behaviors You Have to Ask

29. PrEP Is More Than a Prescription

30. Adherence Strategies Customized for Specific Populations

31. Summary HIV Transmission Prevention Strategies

32. Abbreviations

33. Abbreviations (cont)

34. Abbreviations (cont)

35. References

36. References (cont)

37. References (cont)

38. References (cont)

39. References (cont)

40. References (cont)